Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
OwnerHannelore Ehrenreichinventor
Life of this patent
Estimating the term…
Abstract
The invention provides a method of improving the expanded disability status scale (EDSS) score achieved by mammals affected by multiple sclerosis in which a substance effecting increased and/or prolonged activation and/or stimulation of the erythropoietin (EPO) receptor is administered to the mammal. In certain embodiments, the substance is administered in intervals which are interrupted by application-free periods of time in which said substance is not administered.
Claims20
Method of improving the expanded disability status scale (EDSS) score achieved by a mammal affected by multiple sclerosis, comprising administering to the mammal a substance effecting increased and/or prolonged activation and/or stimulation of an erythropoietin receptor.
-27. (canceled)
Method according to 7, wherein the application-free period lasts 16 to 28 weeks.
Dependencies are inferred from the claim text.